ADEMUS designs and manufactures high-end electric motorcycles that combine traditional French craftsmanship with advanced engineering techniques. These custom-built motorcycles address the demand for sustainable and unique transportation solutions, offering riders a blend of performance and individuality.

The startup offers a cloud-based platform that enhances job site safety by providing real-time alerts for hazardous conditions, thereby preventing accidents during complex operations. Additionally, it optimizes productivity by monitoring performance metrics and minimizing environmental impact, ensuring efficient resource management and compliance with local regulations.

Checkstep offers an AI-driven platform that automates the moderation of user-generated content using machine learning algorithms to detect and filter inappropriate material. This technology minimizes the manual effort required for content review, improving operational efficiency and compliance for online communities and platforms.

Didask provides an integrated LMS/LXP platform that uses AI to automatically convert PDFs, videos, and transcripts into adaptive, micro‑learning modules grounded in cognitive‑science principles. The system delivers real‑time AI coaching and personalized learning paths, integrates via SCORM and native connectors, and continuously updates content based on usage data, enabling enterprises to scale performance‑focused training without extensive instructional design.

Floating Genes develops liquid biopsy-based in vitro diagnostic tests utilizing their proprietary Enhance-seq technology, which employs NGS-based targeted sequencing to detect rare circulating tumor DNA (ctDNA) amidst a background of non-mutated DNA. This technology enables early cancer diagnosis by identifying low-frequency mutations with minimal sequencing depth, addressing the challenge of detecting cancer at its earliest stages.

Gozem is a super app that provides on-demand transportation, delivery, and cashless payment services through a single platform, utilizing GPS tracking and certified drivers to ensure safety and reliability. It addresses the challenges of accessing trustworthy and affordable mobility and delivery options in underserved regions of Francophone West and Central Africa.

Hability provides immersive virtual reality therapeutic exercises designed to complement conventional rehabilitation programs. Their VR platform offers engaging activities that support physical and cognitive recovery for patients.

Inspeere offers a distributed IT backup solution that ensures data security and accessibility for enterprises, utilizing a proprietary technology that protects against ransomware and cyberattacks. The service operates at a flat rate, independent of data volume, providing organizations with reliable data recovery and control over their information without reliance on traditional data centers.

The startup develops mobile applications tailored for tourists, utilizing e-ticketing, access control, and real-time information systems to enhance the travel experience. By streamlining customer journeys and managing visitor flow, the company addresses the complexities of modern tourism consumption patterns.

Kasko provides a modular no-/low-code platform for integrating insurance products into digital services, enabling businesses to launch and manage insurance programs efficiently. The platform addresses the challenge of limited IT resources by offering a comprehensive solution for insurance distribution across the EU and UK.

Kimialys develops proprietary K-One® surface chemistry for the optimal immobilization of ligands on gold surfaces, enhancing the functionality of biosensors used in diagnostics and drug development. Their technology ensures over 90% of ligands remain functional, significantly improving sensitivity and specificity in detecting low concentrations of analytes while minimizing false positives.

Klaim provides a platform that purchases medical claims from healthcare providers, ensuring payment within 24 hours to enhance cash flow and financial stability. This approach addresses the issue of delayed reimbursements, allowing providers to focus on delivering quality care without the burden of unpredictable cash flow.

The startup offers a cloud-based platform for event attendee management that enhances community engagement through targeted communication and data collection tools. By providing subscription-based access to both online and offline marketing solutions, it enables businesses to effectively manage customer interactions and optimize sales strategies.

MAG4Health develops a compact optically pumped magnetometer-based magnetoencephalography (OPM-MEG) system for non-invasive detection of brain functional disorders, providing high spatial and temporal resolution in brain mapping. This technology enhances the localization of abnormal brain activity in patients with epilepsy and brain tumors, improving clinical outcomes and advancing research in neurological disorders.

Mooncard offers a corporate payment card and an automated expense management platform that streamlines the entire process from payment to accounting. By digitizing expense claims and providing real-time visibility, it reduces manual processing time by up to 38 hours per month and ensures 97% of receipts are collected within 24 hours.

MyFit Solutions employs 3D scanning technology to deliver accurate size recommendations and create custom-fit apparel and footwear. This technology directly addresses the issue of poor fit, leading to increased customer satisfaction and lower return rates.

The startup has developed a consolidation technique that enables the production of high-performance materials through flash sintering of powders, minimizing material loss during manufacturing. This method significantly reduces production time for applications in aeronautics, luxury goods, defense, and industrial sectors.

Owkin utilizes AI and multimodal patient data to identify biomarkers and match patient subpopulations with targeted drug candidates, enhancing the precision of drug discovery and development. This approach accelerates clinical trials and improves diagnostic accuracy, ultimately aiming to deliver the right treatment to each patient.

The startup offers an environmental footprint analysis platform that enables fashion brands to monitor and score the environmental impact of their products throughout the supply chain. This tool facilitates compliance with mandatory environmental labeling requirements, allowing marketers to quantify and communicate the sustainability of their offerings.

PEP-Therapy develops targeted peptide therapies for oncology, specifically focusing on PEP-010, which induces apoptosis in cancer cells and can be monitored through pharmacodynamic biomarkers. This approach addresses the challenge of treatment resistance in cancers such as ovarian adenocarcinoma, enhancing therapeutic efficacy both as a monotherapy and in combination with existing treatments like paclitaxel.

Plantibodies produces plant-based monoclonal antibodies using synthetic and molecular biology techniques to target life-threatening diseases such as cancers, neurodegenerative disorders, and autoimmune conditions. This approach enables the generation of stable antibodies from plants, providing a potential therapeutic solution for patients facing these serious health challenges.

The company develops genome editing-based therapies for genetic disorders, oncology, and organ transplants. Their technology enables precise genetic recombination to create off-the-shelf treatments for previously incurable diseases.

The startup specializes in recycling complex plastics into fully recycled and recyclable materials, utilizing advanced processing techniques to convert multi-component plastic packaging into high-quality products. This approach enables a circular economy by facilitating the reuse of all plastics, contributing to a reduction in plastic waste and promoting a plastic-free environment.

SEEKYO is developing targeted chemotherapies that utilize novel drug delivery systems to enhance the efficacy of cancer treatment while minimizing side effects. The company focuses on improving patient outcomes by increasing the precision of drug administration to tumor sites.